Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Increasing Patient Enrollment in Clinical Trials Key to Progress in Cancer Care
Read More
Specialty Pharmacies Add Value in the Management of Cancer Drugs
Read More
Genomic Assays Expediting Adoption of Personalized Cancer Therapy in Clinical Practice
Read More
Practice Management
The Impact of Policy and Politics on Health and Drug Pricing
Read More
Immunotherapy
,
Oncology
Maximizing the Potential of Immunotherapy the Focus of Cancer Moonshot 2020
Read More
Perspectives
Employers Look to Manage the Benefits of Specialty Pharmacy
Read More
Precision Medicine the Future of Cancer Care, but Cost Remains a Major Barrier
Read More
Navigating Patient Assistance Programs
Read More
FDA Approvals
Plethora of Targeted Agents in the Oncology Pipeline
Read More
Perspectives
The Price of PEACE
Read More
96
97
98
99
100
101
102
Page 99 of 244
Results 981 - 990 of 2434